Steven F. Dowdy, Ph.D.

Steven F. Dowdy, Ph.D. is a Professor in the Department of Cellular & Molecular Medicine at the University of California San Diego (UCSD) School of Medicine.13 His research career has been marked by significant contributions to various fields of molecular biology and medicine.

Research Focus

Dr. Dowdy's early research centered on understanding the molecular basis of G1 cell cycle deregulation during oncogenesis.3 Over time, his work evolved to focus on the development of targeted delivery systems for RNAi and ASO therapeutics.2 He is particularly known for pioneering the synthesis of bioreversible, charge-neutral delivery methods for these therapies.2

Career Highlights

Education and Training::

• Ph.D. from the University of California Irvine (UCI) under Prof. Eric Stanbridge
• Postdoctoral research at the Whitehead Institute, MIT, with Prof. Bob Weinberg1

Professional Positions::

• Started his lab in 1994 as an Investigator of the Howard Hughes Medical Institute (HHMI) and an Assistant Professor1
• Currently a Professor at UCSD School of Medicine3

Contributions to Scientific Community

Dr. Dowdy has been actively involved in the Oligonucleotide Therapeutics Society (OTS):

• Joined the editorial board of the Oligonucleotide Journal (now Nucleic Acid Therapeutics) in 2008
• Served on the OTS board of directors from 2015 to 2021
• Organized the 2018 Annual OTS meeting in Seattle
• Currently sits on OTS's science advisory board1

Research Impact

His work has been widely recognized in the scientific community, with over 21,000 citations to his publications.4 Dr. Dowdy's research has implications for various fields, including cancer research and potentially Parkinson's disease.5

Steven F. Dowdy's career exemplifies a commitment to advancing molecular medicine through innovative research and active participation in scientific societies.